European patent was granted for TILTĀ“s patent Enhancing adoptive cell therapy in November 2018. The bibliographical data of the application was published in the European Patent Bulletin 14/2019 in April 2019.
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events:
11-13th December 2024
ESMO Immuno-Oncology Congress
Geneva, Switzerland
13-15th January 2025
Biotech Showcase
San Francisco (CA), USA